Literature DB >> 17544798

Examination of an inducible expression system for limiting iron availability during Chlamydia trachomatis infection.

Brian D Dill1, Jane E Raulston.   

Abstract

The obligate intracellular bacterium Chlamydia trachomatis requires iron in order to complete its developmental cycle. Addition of an iron-chelating drug, Desferal (deferoxamine mesylate), to infected cell culture causes Chlamydia to enter persistence. Here, we explore the ability of a stably-transfected cell line with inducible over-expression of the eukaryotic iron efflux protein ferroportin to starve C. trachomatis serovar E for iron. Ferroportin-induced iron removal is perhaps a more direct method of removing iron from the intracellular compartment versus exposure to an exogenous chemical chelator. Following induction, ferroportin-green fluorescent protein (Fpn-GFP) was detected in the plasma membrane, and cells expressing Fpn-GFP remained viable throughout the timescale required for Chlamydia to complete its developmental cycle. Following Fpn-GFP induction in infected cells, chlamydial infectivity remained unchanged, indicating chlamydiae were not in persistence. Ferritin levels indicate only a small decrease in cellular iron following Fpn-GFP expression relative to cultures exposed to Desferal. These data indicate that expression of Fpn-GFP in chlamydiae-infected cells is not capable of reducing iron below the threshold concentration needed to cause chlamydiae to enter persistence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17544798      PMCID: PMC2083192          DOI: 10.1016/j.micinf.2007.03.017

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  20 in total

1.  Selection for expression of the gonococcal hemoglobin receptor during menses.

Authors:  J E Anderson; P A Leone; W C Miller; C Chen; M M Hobbs; P F Sparling
Journal:  J Infect Dis       Date:  2001-11-06       Impact factor: 5.226

2.  Influence of iron restriction on Chlamydia pneumoniae and C. trachomatis.

Authors:  Heike M Freidank; Heiko Billing; Margit Wiedmann-Al-Ahmad
Journal:  J Med Microbiol       Date:  2001-03       Impact factor: 2.472

Review 3.  Iron homeostasis: insights from genetics and animal models.

Authors:  N C Andrews
Journal:  Nat Rev Genet       Date:  2000-12       Impact factor: 53.242

4.  Low iron availability modulates the course of Chlamydia pneumoniae infection.

Authors:  H M Al-Younes; T Rudel; V Brinkmann; A J Szczepek; T F Meyer
Journal:  Cell Microbiol       Date:  2001-06       Impact factor: 3.715

5.  Action of deferoxamine against Pneumocystis carinii.

Authors:  A B Clarkson; D Turkel-Parrella; J H Williams; L C Chen; T Gordon; S Merali
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

6.  Action and reaction: Chlamydophila pneumoniae proteome alteration in a persistent infection induced by iron deficiency.

Authors:  Wolfgang Wehrl; Thomas F Meyer; Peter R Jungblut; Eva-Christina Müller; Agnes J Szczepek
Journal:  Proteomics       Date:  2004-10       Impact factor: 3.984

Review 7.  Iron and ageing: an introduction to iron regulatory mechanisms.

Authors:  Cathy W Levenson; Nadine M Tassabehji
Journal:  Ageing Res Rev       Date:  2004-07       Impact factor: 10.895

Review 8.  Iron uptake mechanisms of pathogenic bacteria.

Authors:  K G Wooldridge; P H Williams
Journal:  FEMS Microbiol Rev       Date:  1993-11       Impact factor: 16.408

Review 9.  Bacterial iron homeostasis.

Authors:  Simon C Andrews; Andrea K Robinson; Francisco Rodríguez-Quiñones
Journal:  FEMS Microbiol Rev       Date:  2003-06       Impact factor: 16.408

10.  Preliminary observations on lactoferrin secretion in human vaginal mucus: variation during the menstrual cycle, evidence of hormonal regulation, and implications for infection with Neisseria gonorrhoeae.

Authors:  M S Cohen; B E Britigan; M French; K Bean
Journal:  Am J Obstet Gynecol       Date:  1987-11       Impact factor: 8.661

View more
  6 in total

Review 1.  Chlamydia trachomatis strains and virulence: rethinking links to infection prevalence and disease severity.

Authors:  Gerald I Byrne
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

2.  Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae.

Authors:  Hencelyn Chu; Anatoly Slepenkin; Mikael Elofsson; Pia Keyser; Luis M de la Maza; Ellena M Peterson
Journal:  Int J Antimicrob Agents       Date:  2010-06-01       Impact factor: 5.283

3.  Iron depletion limits intracellular bacterial growth in macrophages.

Authors:  Prasad N Paradkar; Ivana De Domenico; Nina Durchfort; Irene Zohn; Jerry Kaplan; Diane McVey Ward
Journal:  Blood       Date:  2008-03-27       Impact factor: 22.113

Review 4.  Ironing Out the Unconventional Mechanisms of Iron Acquisition and Gene Regulation in Chlamydia.

Authors:  Nick D Pokorzynski; Christopher C Thompson; Rey A Carabeo
Journal:  Front Cell Infect Microbiol       Date:  2017-09-08       Impact factor: 5.293

5.  Chlamydia trachomatis alters iron-regulatory protein-1 binding capacity and modulates cellular iron homeostasis in HeLa-229 cells.

Authors:  Harsh Vardhan; Apurb R Bhengraj; Rajneesh Jha; Aruna Singh Mittal
Journal:  J Biomed Biotechnol       Date:  2009-08-16

6.  Neutrophil gelatinase-associated lipocalin and interleukin-10 regulate intramacrophage Chlamydia pneumoniae replication by modulating intracellular iron homeostasis.

Authors:  Rosa Bellmann-Weiler; Andrea Schroll; Sabine Engl; Manfred Nairz; Heribert Talasz; Markus Seifert; Guenter Weiss
Journal:  Immunobiology       Date:  2012-11-21       Impact factor: 3.144

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.